Guided Therapeutics (GTHP) Short Interest Ratio & Short Volume $0.13 0.00 (0.00%) As of 05/21/2025 Add Compare Share Share Short Interest Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Guided Therapeutics Short Interest DataGuided Therapeutics (GTHP) has a short interest of 100 shares. This marks a -97.92% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 15,692 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest4,800 sharesChange Vs. Previous Month-97.92%Dollar Volume Sold Short$10.50Short Interest Ratio0.0 Days to CoverLast Record DateApril 30, 2025Outstanding Shares78,910,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume1 sharesAverage Trading Volume15,692 sharesToday's Volume Vs. Average0% Short Selling Guided Therapeutics? Sign up to receive the latest short interest report for Guided Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGTHP Short Interest Over TimeGTHP Days to Cover Over TimeGTHP Percentage of Float Shorted Over Time Guided Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025100 shares $10.50 -97.9%N/A0 $0.11 4/15/20254,800 shares $432.00 No Change0.0%0.1 $0.09 2/15/202513,800 shares $1,656.00 +40.8%0.1%0.5 $0.12 1/31/20259,800 shares $1,274.00 +25.6%N/A0.3 $0.13 1/15/20257,800 shares $1,113.45 No ChangeN/A0.8 $0.14 12/31/20247,800 shares $1,170.00 No ChangeN/A0.2 $0.15 11/15/2024400 shares $68.00 -96.7%N/A0 $0.17 10/31/202412,000 shares $2,400.00 -2.4%N/A0.2 $0.20 10/15/202412,300 shares $1,723.23 -6.1%N/A4.7 $0.14 9/30/202413,100 shares $2,292.50 +36.5%N/A1.4 $0.18 Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/20249,600 shares $1,824.00 +146.2%N/A1 $0.19 8/31/20243,900 shares $538.20 +1,200.0%N/A0.3 $0.14 8/15/2024300 shares $35.37 -72.7%N/A0 $0.12 7/31/20241,100 shares $132.00 -38.9%N/A0.1 $0.12 7/15/20241,800 shares $239.28 No ChangeN/A0 $0.13 6/15/20242,000 shares $280.00 -52.4%N/A0 $0.14 5/31/20244,200 shares $420.00 -71.0%N/A0.2 $0.10 5/15/202414,500 shares $1,160.00 +137.7%N/A0.1 $0.08 4/30/20246,100 shares $664.90 -77.2%N/A0.5 $0.11 4/15/202426,700 shares $2,563.20 +256.0%N/A0.9 $0.10 3/31/20247,500 shares $866.25 No ChangeN/A0.2 $0.12 2/29/20246,400 shares $918.40 +392.3%N/A0.1 $0.14 2/15/20241,300 shares $187.33 No ChangeN/A0 $0.14 1/15/20241,300 shares $184.60 No ChangeN/A0.1 $0.14 12/31/20231,300 shares $199.55 -45.8%N/A0 $0.15 12/15/20232,400 shares $453.60 +242.9%N/A0.1 $0.19 11/30/2023700 shares $94.50 -70.8%N/A0 $0.14 11/15/20232,400 shares $323.40 -64.2%N/A0.1 $0.13 10/31/20236,700 shares $1,005.00 No ChangeN/A0.2 $0.15 9/15/20234,900 shares $686.00 -53.8%N/A0.3 $0.14 8/31/202310,600 shares $1,590.00 -33.8%N/A0.2 $0.15 8/15/202316,000 shares $2,161.60 -0.6%N/A0.6 $0.14 7/31/202316,100 shares $2,334.50 +26.8%N/A0.7 $0.15 7/15/202312,700 shares $2,667.00 +32.3%N/A1.3 $0.21 6/30/20239,600 shares $2,160.00 +47.7%N/A0.2 $0.23 6/15/20236,500 shares $1,040.00 -55.5%N/A0 $0.16 5/31/202314,600 shares $2,774.00 +89.6%N/A1.2 $0.19 5/15/20237,700 shares $1,309.00 -56.7%N/A0.1 $0.17 4/30/202317,800 shares $4,272.00 +17,700.0%N/A0.8 $0.24 4/15/2023100 shares $28.00 -96.9%N/A0 $0.28White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 3/31/20233,200 shares $736.00 +18.5%N/A0.1 $0.23 3/15/20232,700 shares $796.23 +2,600.0%N/A0.9 $0.29 2/28/2023100 shares $29.00 -95.7%N/A0 $0.29 2/15/20232,300 shares $765.90 +76.9%N/A0.1 $0.33 1/31/20231,300 shares $450.32 No ChangeN/A0.1 $0.35 12/30/20221,200 shares $360.00 -93.9%N/A0 $0.30 12/15/202219,500 shares $6,431.10 -21.4%N/A2.9 $0.33 11/30/202224,800 shares $8,665.12 +13.2%N/A2.5 $0.35 11/15/202221,900 shares $6,132.00 +10.6%N/A1 $0.28 10/31/202219,800 shares $5,940.00 -2.0%N/A0.8 $0.30 10/15/202220,200 shares $9,090.00 -7.8%N/A3.5 $0.45 9/30/202221,900 shares $11,169.00 +10.6%N/A2.3 $0.51 9/15/202219,800 shares $10,543.50 No ChangeN/A2.8 $0.53 8/31/202219,800 shares $9,702.00 -1.5%N/A6.4 $0.49 8/15/202220,100 shares $11,658.00 +133.7%N/A2.4 $0.58 7/31/20228,600 shares $4,472.00 +855.6%N/A1 $0.52 7/15/2022900 shares $512.28 No ChangeN/A0 $0.57 6/15/2022900 shares $427.95 -76.3%N/A0.1 $0.48 5/31/20223,800 shares $1,938.00 +192.3%N/A0.1 $0.51 5/15/20221,300 shares $715.00 No ChangeN/A0.1 $0.55 3/31/2022300 shares $195.00 -83.3%N/A0 $0.65 3/15/20221,800 shares $918.00 +1,700.0%N/A0.2 $0.51 2/28/2022100 shares $52.50 No ChangeN/A0 $0.53 2/15/2022100 shares $62.50 No ChangeN/A0 $0.63 1/31/2022100 shares $60.00 -75.0%N/A0 $0.60 1/15/2022400 shares $240.00 +300.0%N/A0 $0.60 12/31/2021100 shares $58.02 No ChangeN/A0 $0.58 12/15/2021100 shares $64.94 No ChangeN/A0 $0.65 11/30/2021100 shares $67.50 -50.0%N/A0 $0.68 11/15/2021200 shares $114.02 +100.0%N/A0 $0.57 10/29/2021100 shares $57.00 No ChangeN/A0 $0.57 10/15/2021100 shares $54.00 No ChangeN/A0 $0.54 9/30/2021100 shares $55.99 -98.2%N/A0 $0.56 9/15/20215,400 shares $3,345.30 +17.4%N/A0.4 $0.62 8/31/20214,600 shares $2,529.54 +475.0%N/A0.2 $0.55 8/13/2021800 shares $410.16 +700.0%N/A0 $0.51 7/30/2021100 shares $59.00 -95.7%N/A0 $0.59 7/15/20212,300 shares $1,426.00 +35.3%N/A0.3 $0.62 6/30/20211,700 shares $1,071.00 +240.0%N/A0.2 $0.63 6/15/2021500 shares $331.30 +400.0%N/A0 $0.66 5/28/2021100 shares $59.25 No ChangeN/A0 $0.59 5/14/2021100 shares $64.00 -75.0%N/A0 $0.64 4/30/2021400 shares $276.04 No ChangeN/A0 $0.69 3/15/2021100 shares $75.00 -92.3%N/A0 $0.75 2/26/20211,300 shares $1,157.00 -81.4%N/A0 $0.89 2/12/20217,000 shares $3,500.00 -41.2%N/A0.3 $0.50 1/29/202111,900 shares $4,998.00 +5,850.0%N/A0.3 $0.42 1/15/202113,800 shares $5,533.80 +294.3%N/A0.2 $0.40 12/31/20206,600 shares $2,171.40 -52.2%N/A0.5 $0.33 12/15/202013,800 shares $2,497.80 +294.3%N/A0.2 $0.18The DOJ Just Said Your Money Isn’t Yours (Ad)What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.Get your free guide now by clicking here >> 11/30/20203,500 shares $665.00 -78.7%N/A0.1 $0.19 11/15/202016,400 shares $4,608.40 +1,540.0%N/A0.6 $0.28 10/30/20201,000 shares $363.00 +11.1%N/A0.1 $0.36 10/15/2020900 shares $279.18 +125.0%N/A0.2 $0.31 9/30/2020400 shares $148.00 -91.8%N/A0.1 $0.37 9/15/20204,900 shares $1,813.00 -70.8%N/A0.5 $0.37 GTHP Short Interest - Frequently Asked Questions What is Guided Therapeutics' current short interest? Short interest is the volume of Guided Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 100 shares of GTHP short. Learn More on Guided Therapeutics' current short interest. Is Guided Therapeutics' short interest increasing or decreasing? Guided Therapeutics saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 100 shares, a decrease of 97.9% from the previous total of 4,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guided Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Guided Therapeutics: PolyPid Ltd. (0.10%), DarioHealth Corp. (6.14%), Allurion Technologies Inc. (2.23%), Nephros, Inc. (0.09%), Vaso Co. (0.02%), QT Imaging Holdings, Inc. (1.89%), CollPlant Biotechnologies Ltd. (0.02%), NEXGEL, Inc. (1.18%), IRIDEX Co. (2.18%), Nexalin Technology, Inc. (1.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Guided Therapeutics stock? Short selling GTHP is an investing strategy that aims to generate trading profit from Guided Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guided Therapeutics? A short squeeze for Guided Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GTHP, which in turn drives the price of the stock up even further. How often is Guided Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTHP, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies PolyPid Short Squeeze DarioHealth Short Squeeze Allurion Technologies Short Squeeze Nephros Short Squeeze Vaso Short Squeeze QT Imaging Short Squeeze CollPlant Biotechnologies Short Squeeze NEXGEL Short Squeeze IRIDEX Short Squeeze Nexalin Technology Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GTHP) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
